• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Why International Expansion Must Remain a Priority for Cerner, Epic, Allscripts, MEDITECH

Share:

September 2, 2020

Highlights on this story:
  • How the top US acute EHR vendors, namely Cerner, Epic, Allscripts, and MEDITECH (+85% share of US acute market in terms of revenues), have progressed on international expansion.

As highlighted below, there is a significant variance amongst the big four in terms of revenue and share of business outside the US. Cerner has by far the highest revenue at more than $650M in 2019, representing 12% of its business. Whilst MEDITECH has considerably lower revenue than Cerner, its international revenue is broadly similar to a share of its total revenue.

By contrast, Allscripts and MEDITECH each has international business that is comparable in terms of revenues, but as a share of overall revenues, international is much less important for Allscripts.

Allscripts’ international revenue was lower than Epic, Cerner, and Meditech in 2018, however, its growth in 2019 enabled it to overtake MEDITECH and become the third largest of the four vendors in 2019.

Read more here

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Source: Hit Consultant

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Suvida Healthcare Taps Elation EHR to Support Medicare Hispanic SeniorsSuvida Healthcare Taps Elation EHR to Support Medicare Hispanic Seniors
  • IDEAYA Biosciences Announces Acquisition of Proprietary INQUIRE™ Chemical Library to Enhance Synthetic Lethality Drug Discovery PlatformIDEAYA Biosciences Announces Acquisition of Proprietary INQUIRE™ Chemical Library to Enhance Synthetic Lethality Drug Discovery Platform
  • Global Decentralized Clinical Trial 2021 Insights – Growth Opportunities and Strategic ImperativesGlobal Decentralized Clinical Trial 2021 Insights – Growth Opportunities and Strategic Imperatives
  • Geyser Brands Inc. Announces Signing of Letter of Intent to Acquire Brands
  • Menopause Care Platform Gennev Becomes Aetna In-Network ProviderMenopause Care Platform Gennev Becomes Aetna In-Network Provider
  • Stryker Acquires Med Device Company Gauss SurgicalStryker Acquires Med Device Company Gauss Surgical
  • Analysis System for Breast Cancer Diagnosis Solves ‘blackbox Algorithm’ ProblemAnalysis System for Breast Cancer Diagnosis Solves ‘blackbox Algorithm’ Problem
  • Hospital Execs Believe Their EMRS Will Fail to Meet Their Future Needs, Report FindsHospital Execs Believe Their EMRS Will Fail to Meet Their Future Needs, Report Finds

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications